The Tylenol lawsuits allege that the makers of products containing acetaminophen (also known as paracetamol), including J&J, were negligent in not warning the general public — including pregnant women — about the risks posed by the drug to fetal development and in encouraging their widespread use during pregnancy.
The lawsuits also allege that retailers, including Walmart, CVS, Walgreens and others, falsely advertised products containing acetaminophen as being safe for pregnant women and did not warn them about the risks posed to fetal development.
These products have been marketed as safe for pregnant women since the 1950s, despite a significant number of peer-reviewed studies finding that acetaminophen poses serious risks to pregnant women and unborn children.
The authors of a new review of the drug acetaminophen (paracetamol), sold under the brand names Tylenol and Panadol, called for the immediate end of the use of the drug in infants and children, citing the drug’s association with autism spectrum disorder (ASD).
“Our study shows that acetaminophen would never be approved for pediatric use by today’s regulatory standards,” Dr. William Parker, of WPLab, Inc., who led the research team that conducted the review on acetaminophen and autism, told The Defender.
Children born to women who used the painkiller acetaminophen during pregnancy may have an increased risk of developing behavioral problems like attention-deficit hyperactivity disorder (ADHD), according to new research.
In a new study published in the journal JAMA Pediatrics, researchers analyzed data collected from 64,322 mothers and children enrolled in the Danish National Birth Cohort from 1996 to 2002. At each trimester of pregnancy, mothers were asked if they had used any acetaminophen in the past three months. Read more…